SG11201811070SA - Exosome-guided treatment of cancer - Google Patents
Exosome-guided treatment of cancerInfo
- Publication number
- SG11201811070SA SG11201811070SA SG11201811070SA SG11201811070SA SG11201811070SA SG 11201811070S A SG11201811070S A SG 11201811070SA SG 11201811070S A SG11201811070S A SG 11201811070SA SG 11201811070S A SG11201811070S A SG 11201811070SA SG 11201811070S A SG11201811070S A SG 11201811070SA
- Authority
- SG
- Singapore
- Prior art keywords
- exosome
- cancer
- guided treatment
- guided
- treatment
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662352753P | 2016-06-21 | 2016-06-21 | |
PCT/US2017/038515 WO2017223186A1 (en) | 2016-06-21 | 2017-06-21 | Exosome-guided treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201811070SA true SG11201811070SA (en) | 2019-01-30 |
Family
ID=60784697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201811070SA SG11201811070SA (en) | 2016-06-21 | 2017-06-21 | Exosome-guided treatment of cancer |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190234955A1 (zh) |
EP (1) | EP3472623A4 (zh) |
JP (1) | JP2019527343A (zh) |
KR (1) | KR20190032374A (zh) |
CN (1) | CN109716135A (zh) |
AU (1) | AU2017280204A1 (zh) |
CA (1) | CA3027478A1 (zh) |
IL (1) | IL263835A (zh) |
MX (1) | MX2018015797A (zh) |
SG (1) | SG11201811070SA (zh) |
WO (1) | WO2017223186A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2972405A1 (en) | 2014-12-30 | 2016-07-07 | Dow Agrosciences Llc | Use of picolinamide compounds as fungicides |
TW201902357A (zh) * | 2017-05-02 | 2019-01-16 | 美商陶氏農業科學公司 | 用作種子處理之無環吡啶醯胺 |
TWI724521B (zh) * | 2018-08-30 | 2021-04-11 | 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 | 利用胞外囊泡診斷疾病的方法 |
US20230037966A1 (en) * | 2020-01-07 | 2023-02-09 | The Trustees Of The University Of Pennsylvania | Source specific exosomes for determining avoidance of cancer treatment and avoidance of checkpoint inhibitor therapies |
US20230142955A1 (en) * | 2020-02-27 | 2023-05-11 | The Trustees Of The University Of Pennsylvania | Methods of using a multi-analyte approach for diagnosis and staging a disease |
CN115449555B (zh) * | 2022-10-26 | 2023-10-13 | 山东大学 | Adgra2作为乳腺癌化疗疗效和预后评价生物标志物的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103300820A (zh) * | 2012-03-13 | 2013-09-18 | 西门子公司 | 用于冠状动脉狭窄的非侵入性功能评估的方法和系统 |
WO2014028862A1 (en) * | 2012-08-17 | 2014-02-20 | Cornell University | Use of dna in circulating exosomes as a diagnostic marker for metastasic disease |
WO2014167969A1 (ja) * | 2013-04-08 | 2014-10-16 | 塩野義製薬株式会社 | 大腸がんの検出方法 |
CN105431552B (zh) * | 2013-04-12 | 2020-03-03 | 香港中文大学 | 多组学标记在预测糖尿病中的用途 |
HUE046489T2 (hu) * | 2013-12-04 | 2020-03-30 | Univ Texas | Eljárás ráksejtekbõl származó exoszómák izolálására |
JP6531171B2 (ja) * | 2014-06-27 | 2019-06-12 | エックスワイ エバーグリーン テクノロジー カンパニー | Cns由来エクソソームを富化するための方法 |
CN104450901B (zh) * | 2014-11-27 | 2016-09-21 | 广州赛哲生物科技股份有限公司 | 快速诊断川崎病的核酸标记物及其试剂盒 |
-
2017
- 2017-06-21 KR KR1020197001923A patent/KR20190032374A/ko not_active Application Discontinuation
- 2017-06-21 EP EP17816131.1A patent/EP3472623A4/en not_active Withdrawn
- 2017-06-21 SG SG11201811070SA patent/SG11201811070SA/en unknown
- 2017-06-21 CN CN201780038983.XA patent/CN109716135A/zh not_active Withdrawn
- 2017-06-21 CA CA3027478A patent/CA3027478A1/en not_active Abandoned
- 2017-06-21 WO PCT/US2017/038515 patent/WO2017223186A1/en active Search and Examination
- 2017-06-21 US US16/312,185 patent/US20190234955A1/en not_active Abandoned
- 2017-06-21 AU AU2017280204A patent/AU2017280204A1/en not_active Abandoned
- 2017-06-21 JP JP2018567294A patent/JP2019527343A/ja active Pending
- 2017-06-21 MX MX2018015797A patent/MX2018015797A/es unknown
-
2018
- 2018-12-19 IL IL263835A patent/IL263835A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3472623A1 (en) | 2019-04-24 |
KR20190032374A (ko) | 2019-03-27 |
CA3027478A1 (en) | 2017-12-28 |
EP3472623A4 (en) | 2020-01-15 |
MX2018015797A (es) | 2019-05-16 |
WO2017223186A1 (en) | 2017-12-28 |
JP2019527343A (ja) | 2019-09-26 |
IL263835A (en) | 2019-02-03 |
AU2017280204A1 (en) | 2019-01-24 |
CN109716135A (zh) | 2019-05-03 |
US20190234955A1 (en) | 2019-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1258098A1 (zh) | 治療癌症的方法 | |
HK1251409A1 (zh) | 治療癌症的方法 | |
IL260199B (en) | Cancer treatment methods | |
IL261959A (en) | Cancer treatment with tg02 | |
PL3458052T3 (pl) | Leczenie skojarzone nowotworu | |
IL259996A (en) | Combinations for cancer treatment | |
IL265697B1 (en) | Prostate cancer treatment | |
IL262342A (en) | Cancer treatment methods | |
IL263835A (en) | Exosome-guided treatment of cancer | |
ZA201901578B (en) | Combinations including abx196 for the treatment of cancer | |
GB201408297D0 (en) | Treatment of cancer | |
HK1251794A1 (zh) | 癌症治療 | |
IL274748A (en) | Improved cancer treatment | |
GB201417456D0 (en) | Treatment of cancer | |
GB201622214D0 (en) | treatment of cancer | |
GB201704287D0 (en) | Treatment of cancer | |
GB201703857D0 (en) | Treatment of cancer | |
GB201702565D0 (en) | Treatment of cancer | |
GB201604621D0 (en) | Treatment of cancer | |
GB201604293D0 (en) | Treatment of cancer | |
GB201702139D0 (en) | Methods of cancer treatment | |
GB201512723D0 (en) | Treatment of cancer | |
GB201507928D0 (en) | Treatment of cancer | |
GB201504617D0 (en) | Treatment of cancer | |
GB201409362D0 (en) | Treatment of cancer |